The 2024 Multidisciplinary Head and Neck Cancers Symposium will take place February 29 to March 2 in Phoenix and via livestream for virtual attendees.
Media information is available at astro.org/hn24press, and general registration is available at headandnecksymposium.org.
The meeting is cosponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the American Head & Neck Society (AHNS) and the Society for Immunotherapy of Cancer (SITC).
The symposium will feature interactive and case-based discussions that address new multidisciplinary therapies, treatment guidelines, supportive care and disparities in the treatment of head and neck cancer. Highlighted sessions include:
- Two plenary sessions featuring clinical trials reports and studies from medical, surgical and radiation oncologists
- Keynote discussions on increasing diversity in clinical trials and the evolving role of immunotherapy for head and neck cancers
- Panels on topics such as new therapies for recurrent disease, improving survivorship care for patients, and AI and other emerging clinical decision support tools
